Research Tier III
The National MPS Society’s Research Tier III grant funds small, targeted studies using existing data or consensus methods to advance research in mucopolysaccharidosis and mucolipidosis.
Funder: National MPS Society
Due Dates: March 13, 2026 (LOI, Cycle I) | May 22, 2026 (Full Proposal, Cycle I) | August 7, 2026 (LOI, Cycle II) | October 2, 2026 (Full Proposal, Cycle II)
Funding Amounts: Up to $25,000 for 1 year; not renewable.
Summary: Supports focused, smaller-scale research projects on MPS/ML using existing data or consensus methods.
Key Information: One application per lab per cycle; no indirect costs or PI salary allowed.
Description
The National MPS Society’s Research Tier III grant is designed to advance targeted, smaller-scale research initiatives focused on mucopolysaccharidosis (MPS) and mucolipidosis (ML). This program encourages projects that leverage existing data, biospecimens, or clinical consensus approaches (such as Delphi studies) to address specific scientific questions or pilot new ideas. Tier III grants are intended for narrower, shorter-duration studies that may serve as a foundation for future, larger projects. The goal is to foster innovation and collaboration within the MPS/ML research community and accelerate progress toward improved treatments and care.
